mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.006 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.006 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.006 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.007 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.007 |